GLP-1 RAs: Psychiatric, Cognitive, and Quality of Life Effects
This meta-analysis examines the impact of Glucagon-Like Peptide 1 Receptor Agonists (GLP1-RAs), medications used for obesity and diabetes, on the mental health and quality of life of patients. The study analyzed data from 80 randomized clinical trials involving over 107,000 participants with overweight, obesity, or diabetes. Crucially, it found no significant increase in the risk of serious or […]
8 GLP-1 updates
Over the past month, studies have shown Zepbound leads to more weight loss than Wegovy, and GLP-1 drugs may lower obesity-related cancer risk better than bariatric surgery. Here are eight quick updates on the medication class: 1. The percentage of U.S. adults with a GLP-1 prescription increased from 0.9% in 2019 to 4% in 2024 […]
Chutes & Ladders—20-year Novo vet lands first CEO role
In an effort to maximize the earnings potential of its plaque psoriasis cream, Danish dermatology biotech MC2 Therapeutics has hired a former GLP-1 leader to steer the ship. Trine Ahlgreen is the new CEO of MC2, replacing founding CEO Jesper Lange in a planned transition.
Response to Cho et. al’s “GLP-1 Receptor Agonist Use Is Associated with Increased Rates of Acne Vulgaris Diagnosis In Non-Diabetic Obese Women but Not Men: A Retrospective Cohort Study”
Post Content
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best–known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous with a booming weight loss drug market that could hit $139 billion by 2030. Read more…
AgelessRx Broadens GLP-1 Weight Care Options to Advance Longevity-First Healthcare
ANN ARBOR, Mich.–(BUSINESS WIRE)–AgelessRx, a pioneer in longevity and telehealth solutions, is expanding its suite of GLP-1 offerings to better serve customers seeking sustainable, medically guided solutions. The updated offering includes access to Zepbound® via LillyDirect® and the introduction of Compounded Liraglutide + B12. This expansion reflects AgelessRx’s mission to make science-backed, personalized longevity care […]
Could protein bars be the next GLP-1?
Could collagen prove a side effect-free alternative to weight-loss drugs like GLP-1?
Novo Opposes Pharma Tariffs, Urges Crackdown on Illicit Chinese Semaglutide
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, constitutes a national security threat to the U.S.